Trial · NCT07891520
Efficacy of Seated Physical Activity INtervention(SPIN) for Wheelchair Users With Multiple Sclerosis
NCT07891520, Not applicable, Not yet recruiting, The University of Texas Health Science Center, Houston
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Seated Physical Activity INtervention(SPIN) for Wheelchair Users With Multiple Sclerosis. Trials, record NCT07891520. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891520
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Seated Physical Activity INtervention(SPIN) for Wheelchair Users With Multiple Sclerosis
- NCT number
- NCT07891520
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 100 participants, estimated
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Conditions
- Multiple Sclerosis
- Interventions
- SPIN exercise-training, Control Condition (WELL)
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in self reported total minutes per week of moderate-to-vigorous physical activity (MVPA) | Baseline , 16 weeks. | |
| Primary | Change in strength training, assessed by the Leisure Time Physical Activity Questionnaire for People with Disabilities (LTPAQ-D) | Baseline , 16 weeks | Participants report the number of days and average minutes per day spent in mild-, moderate-, and vigorous-intensity aerobic activities during the previous 7 days. Weekly minutes are calculated separately for each intensity and summed to obtain total aerobic physical activity, expressed in minutes per week. Higher values indicate greater participation in leisure-time aerobic physical activity |
| Secondary | Change in device-measured exercise behavior | Baseline , 16 weeks | Physical activity is measured using an ActiGraph GT3X+ triaxial accelerometer worn on the non-dominant wrist for 7 consecutive days. Acceleration data from the three axes are combined to derive vector magnitude activity counts. Total vector magnitude activity counts are calculated using the study-specified accelerometer data processing and aggregation methods. |
| Secondary | Change in Upper-limb function as assessed by the Nine-Hole Peg Test | Baseline , 16 weeks | Upper-limb dexterity is assessed using the Nine-Hole Peg Test (NHPT). Participants are instructed to place nine pegs into a pegboard and remove them as quickly as possible. Performance is measured by the time required to complete the task, recorded in seconds. A decrease in completion time indicates improved manual dexterity. |
| Secondary | Change in Upper-limb function as assessed by the Grip strength using the hand dynamometer | Baseline , 16 weeks | Grip strength is assessed using a hand dynamometer. Participants squeeze the dynamometer according to the study protocol, and grip strength is recorded in kilograms s. An increase in grip strength indicates improved grip force. |
| Secondary | Change in Disability / Activities of Daily Living ( ADL) as assessed by the Barthel Index score | Baseline , 16 weeks | The Barthel Index will be used to assess changes in participants' independence in activities of daily living (ADLs), including feeding, bathing, grooming, dressing, bowel and bladder control, toilet use, transfers, mobility, and stair climbing. Total scores range from 0 to 100 with higher scores indicating greater independence and lower scores indicating greater dependence. |
| Secondary | Change in Health-Related Quality of Life as assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29) | Baseline , 16 weeks | The Multiple Sclerosis Impact Scale-29 (MSIS-29) is a 29-item, patient-reported outcome measure that assesses the physical and psychological impact of multiple sclerosis on health-related quality of life. The scale includes 20 physical-impact items and 9 psychological-impact items. Scores are transformed to a 0-100 scale, with higher scores indicating greater impact of multiple sclerosis and worse health-related quality of life. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891520
GET https://conductscience.org/api/trials/v1/NCT07891520/registered